|
DOR BioPharma Has SPA Clearance From FDA To Start Confirmatory Phase 3 Clinical Trial Of OrBec(R) In GI GVHD (Medical News Today) |
|
DOR BioPharma, Inc. (DOR or the Company) (OTCBB: DORB) announced that it has reached agreement with the US Food and Drug Administration (FDA) on the design of a confirmatory, pivotal Phase 3 clinical trial evaluating its lead product orBec(R) for the treatment of acute gastrointestinal Graft-versus-Host Disease (GI GVHD). read more |
|
Santa Cruz doctor helps save lives of family who ate poisonous ... - San Jose Mercury News |
|
None of the patients underwent transplants. All recovered but one, the 83-year-old grandmother. Her liver recovered but she succumbed to kidney failure. ... read more |
|
MedPAC approves 1% composite rate update in 2010 - NephrOnline |
|
In December, MedPAC recommended that the ESRD composite rate be updated by the projected rate of increase in the ESRD market basket (2.5%) less the ... read more |
|
Mum ready to give kidney - Oxford Mail |
|
Mrs Berry has also signed up to a ‘pairing’ transplant scheme, that allows her to donate a kidney to another person in need of a kidney, whose friend or ... read more |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
